# A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity

> **NCT07476118** · PHASE1 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 150 (estimated)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** Brenipatide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07476118
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07476118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07476118, "A Study of Brenipatide (LY3537031) in Healthy Participants With Overweight or Obesity". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07476118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*